ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR/ARHP Annual Meeting 2018

Abstract Number: 1506

Synovial Tissue Histopathology Findings in EARLY RA. Is It Usefull? Analysis of the Belgian CAP48 Cohort

Chrisitine Galant1, Laurent Meric de Bellefon2, Bernard R. Lauwerys3, Tatiana Sokolova2, Maria Stoenoiu2, Valérie Badot4, Adrien Nzeusseu Toukap3, Frédéric A. Houssiau5 and Patrick Durez2, 1Pathology, Pathology - Cliniques universitaires Saint-Luc - Université Catholique de Louvain - Institut de Recherche Expérimentale et Clinique (IREC), Brussels, Belgium, 2Rheumatology, Rheumatology - Cliniques universitaires Saint-Luc - Université Catholique de Louvain - Institut de Recherche Expérimentale et Clinique (IREC), Brussels, Belgium, 3Department of Rheumatology, Rheumatology - Cliniques universitaires Saint-Luc - Université Catholique de Louvain - Institut de Recherche Expérimentale et Clinique (IREC), Brussels, Belgium, 4Internal Medicine, Internal Medicine - Centre Hospitalier Universitaire Brugmann, Brussels, Belgium, 5Pôle de pathologies rhumatismales systémiques et inflammatoires, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Brussels, Belgium

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR/ARHP Annual Meeting 2018

Keywords: Early Rheumatoid Arthritis and biomarkers

Session Information

Date: Monday, October 22, 2018

Title: Rheumatoid Arthritis – Diagnosis, Manifestations, and Outcomes Poster II: Diagnosis and Prognosis

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

The development of ultrasound (US) guided synovial biopsy will enable synovial tissue collection from small joints and will facilitate histopathological studies, thus improving the understanding of early rheumatoid arthritis (ERA). The CAP48 cohort is an original multicentre prospective observational study of ERA patients (pts) up to 50 years old supported by a charity program of the Belgian French speaking radio-television (RTBF). The objectives of this cohort are to observe if a tight control favours remission at 6 months and to define synovial markers for disease severity and response to therapy.

Methods:

ERA pts fulfilling the ACR/EULAR 2010 criteria and naive to DMARDs therapy were recruited. Synovial biopsies before treatment were obtained using an US guided needle biopsy (US-NB) of the small joints or miniarthroscopy of the knee and used for blinded tissue pathotype description. ERA disease activity measures including DAS28CRP were evaluated every 3 months and treatment was adapted by the treating physician. Tissues were assessed for quality. Pts were classified according 3 types of synovial histopathology findings: pts whose synovial tissue showing mostly lymphoid (CD3+ and CD20+) infiltrates, myeloid (CD68+) infiltrates and a group with low inflammation, combined or not with a fibroid aspect of the stroma, clustered, respectively in Lymphoid, Myeloid and Pauci-Immune groups.

Results:

A synovial biopsy was performed in 37 pts. Baseline characteristics of the cohort and different histologic pattern groups are summarized in Table.

All patients

n=37

‘Lymphoid’

group

n=18

‘Myeloid’

group

n=6

‘Pauci-Immune’

group

n=13

Age

mean (SD)

34.6 (± 11.6)

31.2 (± 10.9)

38.4 (± 11.7)

37.7 (± 11.9)

Gender

30F/7M

14F/4M

5F/1M

11F/2M

ACPA %

37.8% (n= 14)

22.2% (n=4)

0% (n=6)

76.9% (n=10)

RF %

48.6% (n=18)

38.9% (n=7)

16.7% (n=1)

76.9% (n=10)

Erosion %

32.4% (n=12)

27.8% (n=5)

33.3% (n=2)

38.4% (n=5)

Baseline DAS28CRP

4.60 (± 1.37)

4.46 (± 1.42)

5.24 (± 1.52)

4.50 (± 1.26)

6 Month DAS28CRP

2.68 (± 1.13)

2.19 (± 0.89)

*

2.83 (± 1.44)

3.15 (± 1.13)

* p=0.023

ACPA negative pts were classified in the Myeloid (100%) or in Lymphoid (77.8%) groups compared to a majority of the ACPA positive pts (76.9%) in the Pauci-Immune group. Since the myeloid pattern can be associated with a lymphoid infiltration, it raised a question on the relevance to maintain a distinct subgroup. The Pauci-Immune RA group showed lower DAS28-CRP response than the other groups.

Conclusion:

Synovial tissue analysis could provide a step change towards personalized medicine in daily clinical practice for disease stratification and treatment selection of ERA. In the CAP48 cohort, a high number of these young and ERA pts achieved remission at 6 months but a lower response was observed in the Pauci-Immune group. Further analyses are ongoing to define individual synovial markers of severity and response.


Disclosure: C. Galant, None; L. Meric de Bellefon, None; B. R. Lauwerys, None; T. Sokolova, None; M. Stoenoiu, None; V. Badot, None; A. Nzeusseu Toukap, None; F. A. Houssiau, None; P. Durez, None.

To cite this abstract in AMA style:

Galant C, Meric de Bellefon L, Lauwerys BR, Sokolova T, Stoenoiu M, Badot V, Nzeusseu Toukap A, Houssiau FA, Durez P. Synovial Tissue Histopathology Findings in EARLY RA. Is It Usefull? Analysis of the Belgian CAP48 Cohort [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/synovial-tissue-histopathology-findings-in-early-ra-is-it-usefull-analysis-of-the-belgian-cap48-cohort/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/synovial-tissue-histopathology-findings-in-early-ra-is-it-usefull-analysis-of-the-belgian-cap48-cohort/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology